American Tower Corporation (NYSE: AMT) today announced that it is scheduled to present at the Deutsche Bank 33rd Annual Media, Internet and Telecom Conference on Monday, March 10, 2025 at 1:50 p.m. ET...
BOSTON: American Tower Corporation (NYSE: AMT) today announced that it is scheduled to present at the Deutsche Bank 33rd Annual Media, Internet and Telecom Conference on Monday, March 10, 2025 at 1:50 p.m. ET in Palm Beach, Florida.
A live webcast and replay of the presentation will be accessible from the Investor Relations section of American Tower’s website at www.americantower.com/investor-relations.
American Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of nearly 149,000 communications sites and a highly interconnected footprint of U.S. data center facilities. For more information about American Tower, please visit www.americantower.com.
Fonte: Business Wire
Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…
G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes
Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries
Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…
Resecurity, a U.S.-based leader in cyber threat intelligence and risk management solutions, is proud to announce its participation in DSEI Japan 2025,…
Generational Group, a leading mergers and acquisitions advisory firm for privately held businesses, is pleased to announce the sale of Elarasys Worldwide,…
LICT Corporation (“LICT” or the “Company”; OTC Pink®: LICT) reports financial results for the quarter ended March 31, 2025. Total revenues for the first…
BostonGene, a leader in AI-powered solutions for drug discovery and development, today announced that six abstracts have been accepted at the 2025 ASCO…